| Sipuleucel-T immunotherapy for castration-resistant prostate cancer PW Kantoff, CS Higano, ND Shore, ER Berger, EJ Small, DF Penson, ... New England Journal of Medicine 363 (5), 411-422, 2010 | 6575 | 2010 |
| Update on AUA guideline on the management of benign prostatic hyperplasia KT McVary, CG Roehrborn, AL Avins, MJ Barry, RC Bruskewitz, ... The Journal of urology 185 (5), 1793-1803, 2011 | 1550* | 2011 |
| Early detection of prostate cancer: AUA Guideline HB Carter, PC Albertsen, MJ Barry, R Etzioni, SJ Freedland, KL Greene, ... The Journal of urology 190 (2), 419-426, 2013 | 1410 | 2013 |
| Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends R Etzioni, DF Penson, JM Legler, D Di Tommaso, R Boer, PH Gann, ... Journal of the National Cancer Institute 94 (13), 981-990, 2002 | 1209 | 2002 |
| Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology JL Mohler, ES Antonarakis, AJ Armstrong, AV D’Amico, BJ Davis, T Dorff, ... Journal of the National Comprehensive Cancer Network 17 (5), 479-505, 2019 | 1188 | 2019 |
| Long-term functional outcomes after treatment for localized prostate cancer MJ Resnick, T Koyama, KH Fan, PC Albertsen, M Goodman, AS Hamilton, ... New England Journal of Medicine 368 (5), 436-445, 2013 | 1084 | 2013 |
| Overdiagnosis and overtreatment of prostate cancer S Loeb, MA Bjurlin, J Nicholson, TL Tammela, DF Penson, HB Carter, ... European urology 65 (6), 1046-1055, 2014 | 1020 | 2014 |
| Epidemiology and cost of ventral hernia repair: making the case for hernia research BK Poulose, J Shelton, S Phillips, D Moore, W Nealon, D Penson, W Beck, ... Hernia 16, 179-183, 2012 | 893 | 2012 |
| Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study AL Potosky, WW Davis, RM Hoffman, JL Stanford, RA Stephenson, ... Journal of the National Cancer Institute 96 (18), 1358-1367, 2004 | 830 | 2004 |
| Adverse effects of androgen deprivation therapy and strategies to mitigate them PL Nguyen, SMH Alibhai, S Basaria, AV D’Amico, PW Kantoff, NL Keating, ... European urology 67 (5), 825-836, 2015 | 752 | 2015 |
| Prostate cancer, version 1.2016 JL Mohler, AJ Armstrong, RR Bahnson, AV D'Amico, BJ Davis, ... Journal of the National Comprehensive Cancer Network 14 (1), 19-30, 2016 | 738 | 2016 |
| Nationwide trends in mastectomy for early-stage breast cancer KL Kummerow, L Du, DF Penson, Y Shyr, MA Hooks JAMA surgery 150 (1), 9-16, 2015 | 727 | 2015 |
| 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study DF Penson, D McLERRAN, Z Feng, L Li, PC Albertsen, FD Gilliland, ... The Journal of urology 173 (5), 1701-1705, 2005 | 725 | 2005 |
| Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations A Jemal, SA Fedewa, J Ma, R Siegel, CC Lin, O Brawley, EM Ward Jama 314 (19), 2054-2061, 2015 | 522 | 2015 |
| Quantifying the role of PSA screening in the US prostate cancer mortality decline R Etzioni, A Tsodikov, A Mariotto, A Szabo, S Falcon, J Wegelin, ... Cancer Causes & Control 19, 175-181, 2008 | 503 | 2008 |
| Prostate cancer and the Will Rogers phenomenon PC Albertsen, JA Hanley, GH Barrows, DF Penson, PDH Kowalczyk, ... Journal of the National Cancer Institute 97 (17), 1248-1253, 2005 | 441 | 2005 |
| Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years DA Barocas, JA Alvarez, MJ Resnick, T Koyama, KE Hoffman, MD Tyson, ... Jama 317 (11), 1126-1140, 2017 | 370 | 2017 |
| Enzalutamide and survival in nonmetastatic, castration-resistant prostate cancer CN Sternberg, K Fizazi, F Saad, ND Shore, U De Giorgi, DF Penson, ... New England Journal of Medicine 382 (23), 2197-2206, 2020 | 360 | 2020 |
| Enzalutamide versus bicalutamide in castration-resistant prostate cancer: the STRIVE trial DF Penson, AJ Armstrong, R Concepcion, N Agarwal, C Olsson, L Karsh, ... Journal of Clinical Oncology 34 (18), 2098-2106, 2016 | 356 | 2016 |
| NCCN guidelines insights: Prostate cancer, version 1.2021: Featured updates to the NCCN guidelines E Schaeffer, S Srinivas, ES Antonarakis, AJ Armstrong, JE Bekelman, ... Journal of the National Comprehensive Cancer Network 19 (2), 134-143, 2021 | 341 | 2021 |
